Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Weaver, Akshay Vaishnaw, Peter Francis, Michael Catelani, Sigma-Aldrich


People in the News

Sirna Therapeutics said this week that it has named Gregory Weaver as CFO.

Weaver replaces Martin Schmieg, who resigned from the company last year.

According to Sirna, Weaver most recently served as CFO of Nastech Pharmaceutical. Before that, he was CFO of Ilex Oncology. He has a BS from Trinity University and an MBA from Boston College Graduate School of Management.

Alnylam Pharmaceuticals said this week that Akshay Vaishnaw has become the company's vice president of clinical research.

Vaishnaw comes to Alnylam from Biogen Idec, where he was most recently senior director of translational medicine. He holds an MD from the University of Wales College of Medicine, a PhD from the University of London, and an executive MBA from Harvard Business School.

Benitec this week named two new directors.

The company said Peter Francis, a partner at the Australian law firm of Francis Abourizk Lightowlers, has been appointed as a non-executive director.

Additionally, Michael Catelani, the company's CFO, has been appointed as an executive director.


Products & Services

Sigma-Aldrich has recently introduced the Mission TRC shRNA human tumor suppressor gene family, an shRNA gene family set in lentiviral format.

The suppressors are also available as bacterial glycerol stocks, the company said.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.